BIOCRYST PHARMACEUTICALS, INC. Notes Payable, Current
BIOCRYST PHARMACEUTICALS, INC. (BCRX) had Notes Payable, Current of $30.00 million as of 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:NotesPayableCurrent · last filed 2022-02-28
- 2021-09-30: Notes Payable, Current $30.00M.
- 2021-06-30: Notes Payable, Current $30.00M.
- 2021-03-31: Notes Payable, Current $30.00M.
- 2020-12-31: Notes Payable, Current $30.00M.
| Period end | Notes Payable, Current | Notes Payable, Current as first filed |
|---|---|---|
| 2021-09-30 | $30.00M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $30.00M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $30.00M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $30.00M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $29.89M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $29.78M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $29.67M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $29.56M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $29.45M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $29.34M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $29.23M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $29.12M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $29.01M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $28.90M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $28.79M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $28.68M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $28.57M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $28.46M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $28.35M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $28.24M 10-K · filed 2018-03-12 | |
| 2016-09-30 | $28.13M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $28.02M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $27.91M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $27.80M 10-K · filed 2017-02-27 | $30.00M 10-K · filed 2016-02-26 |
| 2014-12-31 | $30.00M 10-K · filed 2016-02-26 | |
| 2014-09-30 | $30.00M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $30.00M 10-Q · filed 2014-08-08 | |
| 2013-12-31 | $0.00 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |